Caspase 3 deregulation studies demonstrate that, in colorectal cancer, CASP3 acts to promote tumor invasiveness and metastasis after exposure to radiation and chemical carcinogens [123], hence it is suggested that targeting CASP3 may increase tumor susceptibility to cancer treatment and inhibit metastasis [124]. Here, CASP3 is linked to neoplasm.